TruAlt Bioenergy Limited (NSE:TRUALT)
India
· Delayed Price · Currency is INR 367.10
-8.00 (-2.13%)
At close: Mar 6, 2026
TruAlt Bioenergy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | - | 19,077 | 12,234 | 7,624 | - | 5,254 |
| Revenue Growth (YoY) | - | 55.94% | 60.47% | - | - | - |
| Cost of Revenue | - | 12,760 | 8,080 | 5,031 | - | 3,560 |
| Gross Profit | - | 6,317 | 4,154 | 2,593 | - | 1,694 |
| Selling, General & Admin | - | 417.82 | 247.07 | 119.49 | - | 68.01 |
| Other Operating Expenses | - | 2,803 | 2,024 | 1,423 | 0.12 | 628.45 |
| Operating Expenses | - | 3,890 | 2,840 | 1,750 | 0.12 | 761.18 |
| Operating Income | - | 2,427 | 1,314 | 842.96 | -0.12 | 932.64 |
| Interest Expense | - | -1,406 | -1,362 | -345.69 | - | -270.62 |
| Interest & Investment Income | - | 592.07 | 502.67 | - | - | 5.06 |
| Currency Exchange Gain (Loss) | - | -0.27 | 0.77 | - | - | - |
| Other Non Operating Income (Expenses) | - | -22.74 | -6.3 | -7.41 | - | -5.63 |
| EBT Excluding Unusual Items | - | 1,590 | 448.73 | 489.85 | -0.12 | 661.45 |
| Gain (Loss) on Sale of Investments | - | 4.26 | 0.01 | - | - | - |
| Pretax Income | - | 1,594 | 448.74 | 489.85 | -0.12 | 661.45 |
| Income Tax Expense | - | 128.04 | 130.66 | 135.25 | - | 166.48 |
| Net Income | - | 1,466 | 318.08 | 354.6 | -0.12 | 494.97 |
| Preferred Dividends & Other Adjustments | - | 5.14 | 58.65 | 29.33 | - | - |
| Net Income to Common | - | 1,461 | 259.43 | 325.27 | -0.12 | 494.97 |
| Net Income Growth | - | 361.01% | -10.30% | - | - | - |
| Shares Outstanding (Basic) | 86 | 70 | 61 | 46 | 0 | 0 |
| Shares Outstanding (Diluted) | 86 | 70 | 61 | 46 | 0 | 0 |
| Shares Change (YoY) | 40.67% | 14.23% | 33.28% | 75023.49% | - | - |
| EPS (Basic) | - | 20.94 | 4.25 | 7.10 | -2.03 | 8114.25 |
| EPS (Diluted) | - | 20.94 | 4.25 | 7.10 | -2.03 | 8114.25 |
| EPS Growth | - | 392.98% | -40.16% | - | - | - |
| Free Cash Flow | - | 696.28 | -3,213 | -420.48 | -0 | -863.36 |
| Free Cash Flow Per Share | - | 9.98 | -52.61 | -9.18 | -0.00 | -14153.39 |
| Gross Margin | - | 33.11% | 33.95% | 34.01% | - | 32.24% |
| Operating Margin | - | 12.72% | 10.74% | 11.06% | - | 17.75% |
| Profit Margin | - | 7.66% | 2.12% | 4.27% | - | 9.42% |
| Free Cash Flow Margin | - | 3.65% | -26.27% | -5.51% | - | -16.43% |
| EBITDA | - | 3,084 | 1,883 | 1,050 | 64.57 | 997.34 |
| EBITDA Margin | - | 16.16% | 15.39% | 13.78% | - | 18.98% |
| D&A For EBITDA | - | 656.87 | 569.17 | 207.52 | 64.69 | 64.69 |
| EBIT | - | 2,427 | 1,314 | 842.96 | -0.12 | 932.64 |
| EBIT Margin | - | 12.72% | 10.74% | 11.06% | - | 17.75% |
| Effective Tax Rate | - | 8.03% | 29.12% | 27.61% | - | 25.17% |
| Revenue as Reported | - | 19,685 | 12,802 | 7,624 | - | 5,259 |
| Advertising Expenses | - | 13.7 | 2.31 | 33.55 | - | 6.2 |
Source: S&P Capital IQ. Standard template. Financial Sources.